Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ulcerative Colitis: Disease Burden, Impact on Daily Life, and Reluctance to Consult Medical Professionals: Results from a Japanese Internet Survey
Toshifumi Hibi∥, Toyomi Ishibashi, Yuka Ikenoue, et al.
Inflammatory Intestinal Diseases (2020) Vol. 5, Iss. 1, pp. 27-35
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Silvio Danese, Séverine Vermeire, Wen Zhou, et al.
The Lancet (2022) Vol. 399, Iss. 10341, pp. 2113-2128
Closed Access | Times Cited: 400
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Geert R. D’Haens, Marla C. Dubinsky, Taku Kobayashi, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 26, pp. 2444-2455
Open Access | Times Cited: 152
Urgency and Its Association With Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
Jared A. Sninsky, Edward L. Barnes, Xian Zhang, et al.
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 5, pp. 769-776
Open Access | Times Cited: 32
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
Marla C. Dubinsky, Alison Potts Bleakman, Remo Panaccione, et al.
The American Journal of Gastroenterology (2023) Vol. 118, Iss. 11, pp. 1940-1953
Open Access | Times Cited: 22
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis
Simon Travis, Alison Potts Bleakman, Marla C. Dubinsky, et al.
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 6, pp. 939-949
Open Access | Times Cited: 18
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis
Subrata Ghosh, Yuri Sánchez González, Wen Zhou, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 12, pp. 2022-2030
Open Access | Times Cited: 41
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
Marla C. Dubinsky, Remo Panaccione, James D. Lewis, et al.
Crohn s & Colitis 360 (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 23
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn’s Disease
Vipul Jairath, Theresa Hunter, Alison Potts Bleakman, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 10, pp. 1831-1842
Open Access | Times Cited: 5
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission
Marla C. Dubinsky, David B. Clemow, Theresa Hunter, et al.
Crohn s & Colitis 360 (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 21
Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases
Bénédicte Caron, Subrata Ghosh, Silvio Danese, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 6, pp. 1403-1413.e27
Open Access | Times Cited: 12
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data
Silvio Danese, Jacinda Tran, Geert R. D’Haens, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 11, pp. 1723-1729
Open Access | Times Cited: 11
Clinical usefulness of hypoxia imaging colonoscopy for the objective measurement of ulcerative colitis disease activity
Shintaro Akiyama, Taku Sakamoto, Mariko Kobayashi, et al.
Gastrointestinal Endoscopy (2024) Vol. 99, Iss. 6, pp. 1006-1016.e4
Closed Access | Times Cited: 4
Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial
Jesse Siffledeen, Sunny Singh, Scott M. Shulman, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1636-1648
Open Access | Times Cited: 4
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies
Taku Kobayashi, Katsuyoshi Matsuoka, Mamoru Watanabe, et al.
Intestinal Research (2024) Vol. 22, Iss. 2, pp. 172-185
Open Access | Times Cited: 4
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting
Millie D. Long, Anita Afzali, Monika Fischer, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 4, pp. 570-578
Open Access | Times Cited: 19
3, 3’-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathway
Ling Yang, Chen Zheng, Yufeng Xia, et al.
Phytomedicine (2023) Vol. 116, pp. 154874-154874
Closed Access | Times Cited: 10
Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: a Japanese National Health and Wellness Survey
Sakiko Hiraoka, Zhezhou Huang, Fei Qin, et al.
Intestinal Research (2025)
Open Access
Development of a Burden Scale for Colonoscopy Experienced by Patients with Inflammatory Bowel Disease
Maya Nunotani, Miho Takahashi, Takuro Miyazaki
Inflammatory Intestinal Diseases (2025) Vol. 10, Iss. 1, pp. 61-75
Open Access
Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn’s Disease: Results from the Japanese CONFIDE Study
Toshifumi Hibi∥, Taku Kobayashi, Masaru Tanaka, et al.
Advances in Therapy (2025)
Open Access
Barrier-Strengthening Effects of Cannabidiol on Porcine Peyer’s Patches
Elisa Boehm, Linda Droessler, Marie-Luise Vollstaedt, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3360-3360
Open Access
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies
Millie D. Long, Stefan Schreiber, Toshifumi Hibi∥, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis
Marla C. Dubinsky, Vipul Jairath, Brian G. Feagan, et al.
BMJ Open Gastroenterology (2023) Vol. 10, Iss. 1, pp. e001115-e001115
Open Access | Times Cited: 7
Why Studying Urgency Is Urgent.
Julia Pakpoor, Simon Travis
PubMed (2023) Vol. 19, Iss. 2, pp. 95-100
Closed Access | Times Cited: 5
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models
Qian Han, Hua-zheng Tang, Min Zou, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 6, pp. 1939-1949
Closed Access | Times Cited: 13
Rectal Urgency Among Patients With Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey
Christina Ha, April N. Naegeli, Rina Lukanova, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 4
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top